In today’s weekly M&A update, Ben Harrington from Betaville website talks about Chinese buyers eyeing a stake in Liverpool, with results expected over the next few weeks.
Harrington goes on to detail Pfizer (NYSE:PFE)’s takeover of Medication for USD 14 billion. Earlier it was Sanofi (NYSE:SNY) who attempted gobbling up Medivation via hostile takeover, says Harrington, however with Medivation gone to Pfizer, Sanofi is looking at Biomarin Pharmaceutical (NASDAQ:BMRN) (a US firm).